| Citation: |
GUAN Hao, NIU Yuan, LIU Qiang. Correlation of programmed cell death receptor 1/programmed cell death ligand 1 signaling pathway related proteins with clinical short-term prognosis in patients with Pseudomonas aeruginosa sepsis[J]. Journal of Clinical Medicine in Practice, 2024, 28(8): 33-38. DOI: 10.7619/jcmp.20234220
|
To investigate the effect of programmed cell death receptor 1/programmed cell death ligand 1 (PD-1/PD-L1) signal pathway associated protein on the short-term clinical prognosis in patients with Pseudomonas aeruginosa (PA) sepsis.
A total of 122 patients with PA sepsis in the General Hospital of Ningxia Medical University from January 2021 to June 2023 were selected as the research objects, and all the patients were treated according to the therapeutic guideline of sepsis and the actual condition of disease. Clinical data and the score of the Acute Physiology and Chronic Health Evaluation Ⅱ (APACHE Ⅱ) were collected; the levels of T lymphocytes (CD3+, CD4+ and CD8+) and the levels of serum PD-1 and PD-L1 in peripheral venous blood were determined before treatment.
Of the 122 PA sepsis patients, 101 cases (82.79%, survival group) survived for 28 days after being admitted to the Emergency Intensive Care Unit or other departments, while 21 cases (17.21%, death group) died. There were significant differences in the ratios of hypertension, chronic obstructive pulmonary disease and chronic liver disease, the APACHE Ⅱ scores, and levels of CD4+, CD4+/CD8+, PD-1 and PDL-1 between the survival group and the death group (P < 0.05). Univariate Logistic regression analysis showed that basic diseases (hypertension, chronic obstructive pulmonary disease, chronic liver disease), the APACHE Ⅱ score, CD4+/CD8+, PD-1 and PD-L1 were all factors influencing the short-term survival of PA sepsis patients (P < 0.01). Multivariate Logistic regression analysis indicated that basic diseases (hypertension, chronic obstructive pulmonary disease, chronic liver disease), the APACHE Ⅱ score, PD-1 and PD-L1 were all significant factors affecting the short-term survival of PA sepsis patients (P < 0.01).
The PD-1/PD-L1 signaling pathway has an impact on the clinical prognosis of PA sepsis patients, and up-regulation of this pathway expression can increase the risk of adverse short-term clinical prognosis in PA sepsis patients.
| [1] |
SUN J, ZHANG X, WANG X F, et al. Gut-liver crosstalk in sepsis-induced liver injury[J]. Crit Care, 2020, 24(1): 614. doi: 10.1186/s13054-020-03327-1
|
| [2] |
LUMLERTGUL N, HALL A, CAMPOROTA L, et al. Clearance of inflammatory cytokines in patients with septic acute kidney injury during renal replacement therapy using the EMiC2 filter (Clic-AKI study)[J]. Crit Care, 2021, 25(1): 39. doi: 10.1186/s13054-021-03476-x
|
| [3] |
TACCONELLI E, CARRARA E, SAVOLDI A, et al. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis[J]. Lancet Infect Dis, 2018, 18(3): 318-327. doi: 10.1016/S1473-3099(17)30753-3
|
| [4] |
YANG M A, LEE N, CHOI E H, et al. Pseudomonas aeruginosa bacteremia in children over ten consecutive years: analysis of clinical characteristics, risk factors of multi-drug resistance and clinical outcomes[J]. Korean Med Sci, 2011, 26(5): 612-618. doi: 10.3346/jkms.2011.26.5.612
|
| [5] |
FERRANDO-MARTINEZ S, SNELL BENNETT A, LINO E, et al. Functional exhaustion of HBV-specific CD8 T cells impedes PD-L1 blockade efficacy in chronic HBV infection[J]. Front Immunol, 2021, 12: 648420. doi: 10.3389/fimmu.2021.648420
|
| [6] |
VOLK V, THEOBALD S J, DANISCH S, et al. PD-1 blockade aggravates epstein-barr virus+ post-transplant lymphoproliferative disorder in humanized mice resulting in central nervous system involvement and CD4+ T cell dysregulations[J]. Front Oncol, 2020, 10: 614876.
|
| [7] |
SINGER M, DEUTSCHMAN C S, SEYMOUR C W, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3)[J]. JAMA, 2016, 315(8): 801-810. doi: 10.1001/jama.2016.0287
|
| [8] |
RHODES A, EVANS L E, ALHAZZANI W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016[J]. Intensive Care Med, 2017, 43(3): 304-377. doi: 10.1007/s00134-017-4683-6
|
| [9] |
林羽. 连续性血液净化治疗对全身炎症反应综合征及脓毒血症患者一氧化氮合酶和降钙素原的影响分析[J]. 中国全科医学, 2023, 26(S1): 47-50. https://www.cnki.com.cn/Article/CJFDTOTAL-QKYX2023S1015.htm
|
| [10] |
ALMALKI W H. The sepsis induced defective aggravation of immune cells: a translational science underling chemico-biological interactions from altered bioenergetics and/or cellular metabolism to organ dysfunction[J]. Mol Cell Biochem, 2021, 476(6): 2337-2344. doi: 10.1007/s11010-021-04066-9
|
| [11] |
TORRES L K, PICKKERS P, VANDER POLL T. Sepsis induced immuno-suppression[J]. Annu Rev Physiol, 2022, 10(84): 157-181.
|
| [12] |
LV X, ZHANG X Y, ZHANG Q, et al. lncRNA NEAT1 aggravates sepsis-induced lung injury by regulating the miR-27a/PTEN axis[J]. Lab Invest, 2021, 101(10): 1371-1381. doi: 10.1038/s41374-021-00620-7
|
| [13] |
高磊, 鲍万国, 齐翀, 等. 降钙素原及其变化率联合序贯器官衰竭评分对脓毒症病情与预后判别的临床价值[J]. 实用医学杂志, 2019, 35(17): 2789-2793. https://www.cnki.com.cn/Article/CJFDTOTAL-SYYZ201917025.htm
|
| [14] |
李乐, 罗苑苑, 温敏勇. 脓毒症中医证型分布、病原学特征及T淋巴细胞亚群与预后的相关性研究[J]. 广州中医药大学学报, 2023, 40(2): 271-277. https://www.cnki.com.cn/Article/CJFDTOTAL-REST202302001.htm
|
| [15] |
丁常聪, 金淑娟, 刘泉波. 儿童铜绿假单胞菌脓毒症的临床特征及预后相关因素分析[J]. 四川医学, 2020, 41(5): 497-501. https://www.cnki.com.cn/Article/CJFDTOTAL-SCYX202005015.htm
|
| [16] |
杨佩, 傅元冬, 许飚, 等. 老年脓毒症患者免疫指标与疾病严重程度及预后的相关性研究[J]. 医学研究生学报, 2022, 35(12): 1298-1303. https://www.cnki.com.cn/Article/CJFDTOTAL-JLYB202212013.htm
|
| [17] |
王宝权, 李男, 付海燕, 等. 重症医学科脓毒症和脓毒性休克患者影响预后相关因素分析[J]. 中国感染与化疗杂志, 2019, 19(5): 499-504. https://www.cnki.com.cn/Article/CJFDTOTAL-KGHL201905011.htm
|
| [18] |
ZHANG K, KONG X Y, LI Y, et al. PD-1/PD-L1 inhibitors in patients with preexisting autoimmune diseases[J]. Front Pharmacol, 2022, 13: 854967.
|
| [19] |
LI H X, ZHENG C, HAN M, et al. The PD-1 pathway in tolerance and autoimmunity[J]. Front Pharmacol, 2022, 13: 854967.
|
| [20] |
CHEN Y X, LIU Y Z, WANG Y, et al. Prevotellaceae produces butyrate to alleviate PD-1/PD-L1 inhibitor-related cardiotoxicity via PPARα-CYP4X1 axis in colonic macrophages[J]. ExClin Cancer Res, 2022, 41(1): 1.
|
| 1. |
王献珍，崔强，吴晓伟，张科伟. 藏红花素调节Hippo信号通路对病理性瘢痕成纤维细胞增殖和凋亡的影响. 微循环学杂志. 2024(01): 14-22 .
| |
| 2. |
王晗，刘正群，朱龙博，李宁，郑梓，闫峻，穆淑琴，孙超. 卫矛醇通过调节Toll样受体4/髓样分化因子88/核因子-κB信号通路缓解脂多糖诱导的猪肠道上皮细胞损伤. 动物营养学报. 2024(06): 3952-3962 .
| |
| 3. |
杜琪斌，吴冬晴，谭艺莲，罗怡然，吴蓓丽，谷丽丽. 中药活性成分对矽肺的药理作用机制研究进展. 环境与职业医学. 2023(08): 981-988 .
| |
| 4. |
Can Huang，Ling Yuan，Yang Niu，Ya-Ting Yang，Yi-Fan Yang，Yi Nan，Hong-Li Dou，Joanna Japhet. Using Network Pharmacology and Molecular Docking Tools to Investigate the Potential Mechanism of Ephedra-Gypsum in the Treatment of Respiratory Diseases. World Journal of Traditional Chinese Medicine. 2023(02): 150-159 .
|
© 2020 《实用临床医药杂志》编辑部
Address: 江苏省扬州市江阳中路136号，扬州大学江阳路北校区14号楼201室China Pos: 225009Tel: 0514-87978917、87978989、87978807
Supported by:
Beijing Renhe Information Technology Co., Ltd.
苏公网安备 32100302010246号
DownLoad: